Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKACA | P17612 | 2/20 | 0.75 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.70 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.68 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | SRC | P12931 | 2/20 | 0.68 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.68 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.68 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.68 |
| ▸ | LDHA | P00338 | 1/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.68 |
| ▸ | FBP1 | P09467 | 1/20 | 0.68 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.68 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.68 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432901 | 0.89 | PRKACA (0.71) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL7226454 | 0.89 | HINT1 (0.78) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL1000840 | 0.89 | HINT1 (0.78) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL9426538 | 0.89 | PRKACA (0.73) | PRKACAADORA1ADORA3ADORA2AADORA2B | |
| SCHEMBL19859780 | 0.89 | ADORA1 (0.73) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL2463542 | 0.89 | PRKACA (0.73) | PRKACAADORA1ADORA3ADORA2AADORA2B | |
| SCHEMBL1757017 | 0.89 | ADORA1 (0.73) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL1961271 | 0.88 | PRKACA (0.70) | PRKACAPLA2G2AADORA1ADORA3ADORA2A | |
| SCHEMBL219554 | 0.88 | P2RY1 (0.71) | PRKACAADORA1ADORA3ADORA2AADORA2B | |
| SCHEMBL31001632 | 0.88 | P2RY1 (0.71) | PRKACAADORA1ADORA3ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040242531-A1 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | ADERIS PHARMACEUTICALS, INC. | 2004-12-02 | — | — | US | disclosed |
| US-20040242531-A1 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | ADERIS PHARMACEUTICALS, INC. | 2004-12-02 | — | — | US | disclosed |
| US-20040242930-A1 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | ADERIS PHARMACEUTICALS, INC. | 2004-12-02 | — | — | US | disclosed |
| US-6784165-B1 | ADENOSINE A1 RECEPTOR AGONISTS | ADERIS PHARMACEUTICALS, INC. | 2004-08-31 | — | — | US | disclosed |
| US-6784165-B1 | ADENOSINE A1 RECEPTOR AGONISTS | ADERIS PHARMACEUTICALS, INC. | 2004-08-31 | — | — | US | disclosed |
| EP-1239864-A1 | TREATMENT OF HEART RHYTHM DISTURBANCES WITH N6 -SUBSTITUTED-5'-(N-SUBSTITUTED) CARBOXAMIDOADENOSINES | Aderis Pharmaceuticals, Inc. (US) | 2002-09-18 | — | — | EP | disclosed |
| EP-1239864-A1 | TREATMENT OF HEART RHYTHM DISTURBANCES WITH N6 -SUBSTITUTED-5'-(N-SUBSTITUTED) CARBOXAMIDOADENOSINES | Aderis Pharmaceuticals, Inc. (US) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001037845-A1 | TREATMENT OF HEART RHYTHM DISTURBANCES WITH N6-SUBSTITUTED-5'-(N-SUBSTITUTED) CARBOXAMIDOADENOSINES | ADERIS PHARMACEUTICALS, INC. (US) | 2001-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242930-A1 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | ADRA1D, ADORA1, ADRA2C | PRKACA 4504/4885PLA2G2A 746/4885ADORA1 2/4885 |
| US-20040242531-A1 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | ADRA1D, ADORA1, ADRA2C | PRKACA 4504/4885PLA2G2A 746/4885ADORA1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.